The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer

被引:7
|
作者
Euhus, Caleb J. [1 ]
Ripley, Taylor R. [1 ]
Medina, Cristian G. [1 ]
机构
[1] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Thorac Surg, 1 Moursund St, Houston, TX 77030 USA
关键词
oligometastatic non-small cell lung cancer; metastatic non-small cell lung cancer; NSCLC history; lung cancer staging; surgery and NSCLC; local consolidative therapy (LCT); locally-aggressive therapy (LAT); LONG-TERM SURVIVAL; PROGNOSTIC-FACTORS; THERAPY; RADIOTHERAPY; CLASSIFICATION; MULTICENTER; PROGRESSION; METASTASIS; MANAGEMENT; RESECTION;
D O I
10.3390/cancers14102524
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary This article clarifies the context and definition of the term oligometastasis as it applies to non-small cell lung cancer and reviews the current results in the use of surgery for its management. Ideally after reading this article, practitioners will be better equipped to pick patients for locally aggressive therapy, and researchers will be primed to design the next generation of studies that prioritize treatments in the management of this historically deadly disease. Oligometastatic non-small cell lung cancer (NSCLC) is metastatic disease that refers to a limited number of metastatic sites. It is analogous to an intermediate stage of NSCLC, between localized and widely metastatic disease, even though no staging criteria establishes this distinction. Oligometastatic NSCLC describes a patient subgroup with limited metastasis to one or a few organs. These patients seem to have a more indolent cancer than those with diffuse metastasis. For these select patients with oligometastatic disease, the use of palliative systemic therapy over local aggressive treatment may be a missed opportunity to improve survival. The clear definition of this subgroup and identification of the best treatment remains the current challenge in the management of the disease. Surgery was the early cornerstone in the treatment of limited disease; however, as modalities such as chemotherapy, stereotactic radiosurgery, and immunotherapy have matured, the role of excision is less clearly defined. There are sparse randomized controlled trials comparing the efficacy of different treatment modalities in patients with oligometastatic NSCLC. However, there is a growing body of retrospective research detailing the prognostic factors that characterize the role of surgery in the management of these patients. This article clarifies the context and definition of the term oligometastatic, as it applies to NSCLC, and reviews the current results in the use of surgery for its management.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Management of Oligometastatic Disease in Advanced Non-Small Cell Lung Cancer
    West, Howard
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 249 - +
  • [32] Surgical Treatment of Extrapulmonary Oligometastatic Non-small Cell Lung Cancer
    Ploenes, Till
    Osei-Agyemang, Thomas
    Krohn, Alexander
    Passlick, Bernward
    INDIAN JOURNAL OF SURGERY, 2015, 77 : S216 - S220
  • [33] Current treatment landscape for oligometastatic non-small cell lung cancer
    Garde-Noguera, Javier
    Martin-Martin, Margarita
    Obeso, Andres
    Lopez-Mata, Miriam
    Royo Crespo, Inigo
    Pelari-Mici, Lira
    Juan Vidal, O.
    Mielgo-Rubio, Xabier
    Carlos Trujillo-Reyes, Juan
    Counago, Felipe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2022, 13 (06): : 485 - 495
  • [34] Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer
    Santos, Patricia Mae G.
    Li, Xingzhe
    Gomez, Daniel R.
    CANCERS, 2022, 14 (16)
  • [35] Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
    Sundahl, Nora
    Lievens, Yolande
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (07) : 3420 - 3431
  • [36] Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer
    Jones, Gregory D.
    Lengel, Harry B.
    Hsu, Meier
    Tan, Kay See
    Caso, Raul
    Ghanie, Amanda
    Connolly, James G.
    Bains, Manjit S.
    Rusch, Valerie W.
    Huang, James
    Park, Bernard J.
    Gomez, Daniel R.
    Jones, David R.
    Rocco, Gaetano
    CANCERS, 2021, 13 (08)
  • [37] Surgical approaches in patients with oligometastatic non-small cell lung cancer
    Bertolaccini, Luca
    Pardolesi, Alessandro
    Parri, Sergio Nicola Forti
    Bonfanti, Barbara
    Brandolini, Jury
    Solli, Piergiorgio
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 498 - 502
  • [38] SURGERY FOR NON-SMALL CELL LUNG CANCER
    Vrtik, Marosh
    Alam, Naveed Z.
    CANCER FORUM, 2013, 37 (02) : 150 - 153
  • [39] Surgery for non-small cell lung cancer
    Van Schil, PE
    LUNG CANCER, 2001, 34 : S127 - S132
  • [40] Oligometastatic Non-Small Cell Lung Cancer Treated With Curative Intent
    Walker, P.
    Rosenman, J.
    Arastu, H.
    Leinweber, C.
    Aljumaily, R.
    Biswas, T.
    Russo, S.
    Parent, T.
    Eubanks, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S48 - S48